Search research articles
Contact Us
Filters
Showing results (131-140 of 254) with videos related to
Page
of 26
Sort By:
Journal of the Pediatric Infectious Diseases Society
|
December 2, 2015
Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia
Brian T Fisher, Julia Shaklee Sammons, Yimei Li, et al.
Neuro-Oncology
|
January 12, 2022
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1
Chelsea Kotch, Robert Avery, Kelly D Getz, et al.
Journal of Clinical Pharmacology
|
April 19, 2017
Population Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model-Based Support for Body Surface Area-Based Dosing Over the 2- to 16-Year Age Range
Michael J Hanley, Diane R Mould, Timothy J Taylor, et al.
Pediatric Blood & Cancer
|
April 15, 2024
Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study
Juliette Renaud, Bianca F Goemans, Franco Locatelli, et al.
BMC Medical Genetics
|
June 2, 2011
Novel variants in the PRDX6 Gene and the risk of Acute Lung Injury following major trauma
Melanie Rushefski, Richard Aplenc, Nuala Meyer, et al.
American Journal of Hematology
|
November 19, 2016
The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia
Lena E Winestone, Kelly D Getz, Tamara P Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2008
Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group
Richard Aplenc, Todd A Alonzo, Robert B Gerbing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Journal of the National Cancer Institute
|
November 23, 2020
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma
Kira Bona, Yimei Li, Lena E Winestone, et al.
Pediatric Blood & Cancer
|
September 2, 2021
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group
Kelly D Getz, Todd A Alonzo, Lillian Sung, et al.
Page
of 26
Search research articles
Search
Showing results (131-140 of 254) with videos related to
Sort By:
Page
of 26
Journal of the Pediatric Infectious Diseases Society
|
December 2, 2015
Variation in Risk of Hospital-Onset Clostridium difficile Infection Across β-Lactam Antibiotics in Children With New-Onset Acute Lymphoblastic Leukemia
Brian T Fisher, Julia Shaklee Sammons, Yimei Li, et al.
Neuro-Oncology
|
January 12, 2022
Risk factors for treatment-refractory and relapsed optic pathway glioma in children with neurofibromatosis type 1
Chelsea Kotch, Robert Avery, Kelly D Getz, et al.
Journal of Clinical Pharmacology
|
April 19, 2017
Population Pharmacokinetic Analysis of Bortezomib in Pediatric Leukemia Patients: Model-Based Support for Body Surface Area-Based Dosing Over the 2- to 16-Year Age Range
Michael J Hanley, Diane R Mould, Timothy J Taylor, et al.
Pediatric Blood & Cancer
|
April 15, 2024
Characteristics and treatment of acute myeloid neoplasms with cutaneous involvement in infants up to 6 months of age: A retrospective study
Juliette Renaud, Bianca F Goemans, Franco Locatelli, et al.
BMC Medical Genetics
|
June 2, 2011
Novel variants in the PRDX6 Gene and the risk of Acute Lung Injury following major trauma
Melanie Rushefski, Richard Aplenc, Nuala Meyer, et al.
American Journal of Hematology
|
November 19, 2016
The role of acuity of illness at presentation in early mortality in black children with acute myeloid leukemia
Lena E Winestone, Kelly D Getz, Tamara P Miller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 10, 2008
Safety and efficacy of gemtuzumab ozogamicin in combination with chemotherapy for pediatric acute myeloid leukemia: a report from the Children's Oncology Group
Richard Aplenc, Todd A Alonzo, Robert B Gerbing, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 28, 2021
Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric <i>KMT2A</i>-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531
Jessica A Pollard, Erin Guest, Todd A Alonzo, et al.
Journal of the National Cancer Institute
|
November 23, 2020
Poverty and Targeted Immunotherapy: Survival in Children's Oncology Group Clinical Trials for High-Risk Neuroblastoma
Kira Bona, Yimei Li, Lena E Winestone, et al.
Pediatric Blood & Cancer
|
September 2, 2021
Cytarabine dose reduction in patients with low-risk acute myeloid leukemia: A report from the Children's Oncology Group
Kelly D Getz, Todd A Alonzo, Lillian Sung, et al.
Page
of 26